LifeProNow
FEBRUARY 2, 2025
January 30, 2025: “The U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.
Express Pharma
FEBRUARY 2, 2025
Lupin has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection (PAI) of Edaravone Oral Suspension, 105 mg/5 mL, at its manufacturing facility in Somerset, New Jersey. The inspection was conducted from January 28 to February 1, 2025, and concluded with zero 483 observations. Commenting on the development, Nilesh Gupta, Managing Director, Lupin, said, The successful outcome of the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
FEBRUARY 2, 2025
By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The rules were implemented to enhance patient safety protections via revised drug handling, packaging, and delivery requirements.
Pharmacy Joe
FEBRUARY 2, 2025
In this episode, I’ll discuss the use of methylene blue for the treatment of refractory anaphylaxis without hypotension. Episode 997: The use of methylene blue for the treatment of refractory anaphylaxis without hypotension Subscribe on iTunes , Android , or Stitcher Methylene blue has some unique uses such as in the treatment of acquired methemoglobinemia and vasoplegia after cardiac surgery.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
pharmaphorum
FEBRUARY 2, 2025
Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 2, 2025
Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.
Express Pharma
FEBRUARY 2, 2025
Sanjaya Mariwala, President of the IMC Chamber of Commerce and Industry and Executive Chairman & Managing Director of OmniActive Health Technologies: “The Union Budget delivered today showcases a clear vision for Indias economic future. The reforms in income tax structure will put more money in the citizens pockets, creating a cycle of spending and growth.
STAT
FEBRUARY 2, 2025
On Sunday, the National Science Foundation announced that its payment system was back online to comply with a judge’s order, five days after the agency froze funding to researchers. While post-doctoral fellows were relieved that they could now request the checks they rely on to pay for rent, food, and credit card bills, some remain concerned about what they see as contradictory messages that the funding agency has put out, and worry their grants and livelihoods may still be at risk.
STAT
FEBRUARY 2, 2025
On Saturday, President Trump ordered import taxes on goods from Canada, China, and Mexico, a move that could raise costs for consumers across the economy, including in health care. Tariffs of 25% on imports from Canada (except energy) and Mexico, and 10% on goods from China take effect on Tuesday. Trump said the tariffs will remain in place until those countries stop the flow of fentanyl and undocumented immigrants into the United States.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expert insights. Personalized for you.
130 
Let's personalize your content